Early childhood nutrition and adult metabolomic and cardiometabolic profiles

幼儿营养和成人代谢组学和心脏代谢特征

基本信息

  • 批准号:
    8630478
  • 负责人:
  • 金额:
    $ 53.6万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2014
  • 资助国家:
    美国
  • 起止时间:
    2014-04-10 至 2019-03-31
  • 项目状态:
    已结题

项目摘要

PROJECT SUMMARY / ABSTRACT Nutrition and infection are key determinants of child growth and survival. Chronic inflammation, which results in part from an increased lifetime burden of infectious disease, is an underlying determinant of adult cardiometabolic disease. The modifiability of this risk by improving nutrition in early life is unknown. Our principal objective is to determine whether improvements in early-life nutrition can attenuate the development of cardiometabolic risk. We will collect new data from the INCAP (Guatemala) Nutrition Supplementation Trial cohort. From 1969-77, 2392 children received atole, a high protein and calorie supplement, or fresco, a low calorie drink, for up to 8 y. Children who received atole in the first 3 y of life grew better in childhood and recovered more quickly from diarrheal illness episodes than did children who received fresco. We have followed this cohort prospectively. We propose to re-contact the surviving members of the cohort. The cohort will be 38-53 y old, an ideal age to assess cardiometabolic risk. We will conduct clinical examinations, including (for the first time in this cohort) collection of biomarkers of cardiometabolic risk. We will assay the samples for established and novel biomarkers, including highly innovative metabolomic profiling. We will update and enhance the extensive life-course data that we collected in previous surveys. We will link the new data to our existing rich database to address critical questions regarding the long-term effects on cardiometabolic health of both chronic under-nutrition and an effective intervention to combat under-nutrition, in the context of a community-randomized trial that controls for otherwise intractable questions of endogeneity. The study will be unique in its ability to address unanswered questions relating to early life determinants of adult health. This prospectively-studied cohort has reached an age where the prevalence of cardiometabolic risk is non-negligible. The highly productive research team has extensive experience with survey work among this cohort, demonstrated capacity to link data across study waves, and extensive experience with the appropriate field methods, laboratory methods, and statistical approaches to data analysis. The resulting extensive repository of data and samples will enhance the value of the cohort for future research. Taken together, these elements ensure that the study will be well positioned to successfully address critical understudied questions in human health and development.
项目总结/摘要 营养和感染是儿童生长和存活的关键决定因素。慢性炎症, 部分原因是终生感染性疾病的负担增加, 成人心脏代谢疾病的决定因素。通过改善营养可以改变这种风险 早期的生活是未知的。 我们的主要目标是确定早期营养的改善是否会减弱 心脏代谢风险的发展。我们将从INCAP(危地马拉)收集新数据 营养补充试验队列。从1969年至1977年,2392名儿童获得了阿托莱, 蛋白质和热量补充剂,或fresco,一种低热量饮料,最多8年。的儿童 在生命的前3年接受了atole,在童年时期生长得更好, 比那些接受壁画的孩子更容易生病。我们跟踪了这群人 前瞻性地。我们建议重新联系幸存者。则将队列 38-53岁是评估心脏代谢风险的理想年龄。我们将进行临床检查, 包括(在该队列中首次)收集心脏代谢风险的生物标志物。我们将 分析样品中已建立的和新的生物标志物,包括高度创新的 代谢组学分析我们将更新和增强我们所掌握的广泛的生命过程数据, 在以前的调查中收集。我们将把新的数据链接到我们现有的丰富的数据库, 关于长期影响心脏代谢健康的关键问题, 营养不良和有效干预,以消除营养不良, 社区随机试验,控制其他棘手的内分泌问题。 这项研究将是独一无二的,它能够解决与早期生活有关的悬而未决的问题。 成人健康的决定因素。这个前瞻性研究的队列已经到了一个年龄, 心脏代谢风险的普遍性不可忽略。高效率的研究团队 在这一群体中具有广泛的调查工作经验,证明有能力将数据联系起来 跨研究波,并在适当的现场方法,实验室 方法和数据分析的统计方法。由此产生的大量数据存储库 和样本将提高队列的价值,为未来的研究。综上所述各项 这些因素确保研究能够成功地解决关键问题, 对人类健康和发展的研究不足。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ARYEH DAVID STEIN其他文献

ARYEH DAVID STEIN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ARYEH DAVID STEIN', 18)}}的其他基金

Adult epigenetics and telomere length in relation to improved nutrition in early life
成人表观遗传学和端粒长度与改善早期营养有关
  • 批准号:
    10562425
  • 财政年份:
    2023
  • 资助金额:
    $ 53.6万
  • 项目类别:
Early childhood nutrition and adult metabolomic and cardiometabolic profiles
幼儿营养和成人代谢组学和心脏代谢特征
  • 批准号:
    9058129
  • 财政年份:
    2014
  • 资助金额:
    $ 53.6万
  • 项目类别:
Early childhood nutrition and adult metabolomic and cardiometabolic profiles
幼儿营养和成人代谢组学和心脏代谢特征
  • 批准号:
    9254217
  • 财政年份:
    2014
  • 资助金额:
    $ 53.6万
  • 项目类别:
Education and Health Across the Life course in Guatemala
危地马拉终生教育和健康
  • 批准号:
    7007346
  • 财政年份:
    2004
  • 资助金额:
    $ 53.6万
  • 项目类别:
Education and Health Across the Life course in Guatemala
危地马拉终生教育和健康
  • 批准号:
    6736658
  • 财政年份:
    2004
  • 资助金额:
    $ 53.6万
  • 项目类别:
Education and Health Across the Life course in Guatemala
危地马拉终生教育和健康
  • 批准号:
    6849299
  • 财政年份:
    2004
  • 资助金额:
    $ 53.6万
  • 项目类别:
Zinc, Mental Health and School Performance in Mexico
墨西哥的锌、心理健康和学校表现
  • 批准号:
    7233666
  • 财政年份:
    2004
  • 资助金额:
    $ 53.6万
  • 项目类别:

相似海外基金

Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 53.6万
  • 项目类别:
    Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 53.6万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 53.6万
  • 项目类别:
    Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 53.6万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 53.6万
  • 项目类别:
    Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 53.6万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 53.6万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 53.6万
  • 项目类别:
    Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 53.6万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Collaborative Research: Changes and Impact of Right Ventricle Viscoelasticity Under Acute Stress and Chronic Pulmonary Hypertension
合作研究:急性应激和慢性肺动脉高压下右心室粘弹性的变化和影响
  • 批准号:
    2244994
  • 财政年份:
    2023
  • 资助金额:
    $ 53.6万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了